This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benitec Biopharma Inc BNTC
$11.71
▼ -1.26%
($-0.15)
⬇️ Below Yest. Low
Open
$11.84
Prev Close
$11.86
Day Range
$11.11 – $11.92
52W Range
$9.85 – $16.76
Market Cap
$402.29M
Beta
0.28
EPS (TTM)
$-1.11
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2012-07-11 |
| Shares Out. | 34,350,000 |
| Website | benitec.com/ ↗ |
| Phone | 15107800819 |
| Employees | 19 |
| Net Income | -$11.9M |
| Free Cash Flow | -$19.8M |
| Total Assets | $187.0M |
| Total Liabilities | $3.7M |
| Equity | $183.3M |
About Benitec Biopharma Inc
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Benitec Biopharma Inc is a publicly traded company under the ticker symbol BNTC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-07-01)